WELLESLEY, Massachusetts, May 26, 2016 /PRNewswire/ --
Since its commercial introductionin 2005, next-generation sequencing (NGS) has matured into an essential life science tool for conducting genetic studies in a range of research and development applications. BCC Research reveals in its new report that the industry sits on the beginnings
(Logo: http://photos.prnewswire.com/prnh/20140723/694805 )
Since the Human Genome Project (HGP) was completed in 2003, the life sciences industry has undergone a major transformation. DNA sequencing technologies have led the way in this transformation. Sequencing markets center around three generations of platforms: Sanger sequencing, next-generation sequencing (NGS), and third-generation sequencing (3GS).
The worldwide market for sequencing products was $5.9 billion in 2015 and is forecast to grow at a five-year compound annual growth rate (CAGR) of 18.7% to reach nearly $13.8 billion by the year 2020. The market can be segmented into pre- and post-sequencing products (i.e., sample preparation reagents and kits, and informatics); sequencing instruments and consumables (i.e., flow cells and consumables used in the sequencing reaction itself); and sequencing services. Sequencing services, the largest market segment, also is the fastest-growing one with an anticipated five-year CAGR of 26%.
For clinical, the main applications driving growth are cancer and reproductive health. In cancer, there is a growing need for genomic profiling tests that can be used as the basis for treatment decisions. This is part of a general trend for characterizing cancer on a genomics, rather than anatomic, basis. Also, the maturation of large-scale government research initiatives like the Cancer Genome Atlas should spur growth in this market. These projects help to uncover the underlying genomic basis for cancer, creating a need for sequencing diagnostics to help evaluate, treat and monitor cancer cases.
Non-invasive prenatal diagnostics (NIPT), for high-risk women, should drive growth in the reproductive health application. In-vitro fertilization, carrier screening, newborn screening, and NIPT for average-risk women are anticipated as key drivers, as well.
"Next-generation sequencing, commercially introduced in 2005, is still experiencing high growth in new market applications such as clinical and consumer sequencing," says BCC Research analyst John Bergin. "Emerging sequencing systems, such as single molecular or nanopore sequencing, are still in an early market stage, with platforms only recently introduced. These new sequencing technologies promise to fill new market niches that are presently underserved by the main sequencing technologies."
DNA Sequencing: Emerging Technologies and Applications (BIO045F) analyzes major sequencing trends as well as the key companies and industry sectors. The in-depth analysis provides insights into sequencing's transition into clinical and applied markets, giving a solid roadmap to participants and new entrants into this dynamic industry. Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020 also are provided.
About BCC Research BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key market participants. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Recently selected as the world's greatest market research company, BCC Research is a unit of Eli Global, LLC.
Contact: Steven Cumming Tel: +1-978-870-3345 Fax: +1-781-489-7308 Email: [email protected]
Visit our website at http://www.bccresearch.com Contact us: (+1) 781-489-7301 (U.S. Eastern Time), or email [email protected]
SOURCE BCC Research LLC
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All